HK1211859A1 - Abuse deterrent pharmaceutical composition comprising konjac glucomannan - Google Patents
Abuse deterrent pharmaceutical composition comprising konjac glucomannanInfo
- Publication number
- HK1211859A1 HK1211859A1 HK15112841.9A HK15112841A HK1211859A1 HK 1211859 A1 HK1211859 A1 HK 1211859A1 HK 15112841 A HK15112841 A HK 15112841A HK 1211859 A1 HK1211859 A1 HK 1211859A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical composition
- konjac glucomannan
- abuse deterrent
- deterrent pharmaceutical
- abuse
- Prior art date
Links
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 title 1
- 241001312219 Amorphophallus konjac Species 0.000 title 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 title 1
- 229920002581 Glucomannan Polymers 0.000 title 1
- 229920002752 Konjac Polymers 0.000 title 1
- 229940046240 glucomannan Drugs 0.000 title 1
- 235000010485 konjac Nutrition 0.000 title 1
- 239000000252 konjac Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2791206A CA2791206A1 (en) | 2012-09-28 | 2012-09-28 | Abuse deterrent pharmaceutical formulation |
PCT/CA2013/000835 WO2014047731A1 (en) | 2012-09-28 | 2013-09-30 | Abuse deterrent pharmaceutical composition comprising konjac glucomannan |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1211859A1 true HK1211859A1 (en) | 2016-06-03 |
Family
ID=50382806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15112841.9A HK1211859A1 (en) | 2012-09-28 | 2015-12-30 | Abuse deterrent pharmaceutical composition comprising konjac glucomannan |
Country Status (6)
Country | Link |
---|---|
US (2) | US20150250886A1 (xx) |
EP (1) | EP2900272B1 (xx) |
CA (2) | CA2791206A1 (xx) |
ES (1) | ES2685965T3 (xx) |
HK (1) | HK1211859A1 (xx) |
WO (1) | WO2014047731A1 (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10195153B2 (en) | 2013-08-12 | 2019-02-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
EP3164117B1 (en) | 2014-07-03 | 2023-09-06 | SpecGx LLC | Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides |
ES2809458T3 (es) | 2014-07-17 | 2021-03-04 | Pharmaceutical Manufacturing Res Services Inc | Forma de dosificación llena de líquido, disuasoria del abuso y de liberación inmediata |
US9737609B2 (en) * | 2014-08-20 | 2017-08-22 | Professional Compounding Centers Of America (Pcca) | Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions |
CA2964628A1 (en) | 2014-10-20 | 2016-04-28 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
CA3013321A1 (en) | 2016-02-08 | 2017-08-17 | SpecGx LLC | Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties |
EP3473246A1 (en) | 2017-10-19 | 2019-04-24 | Capsugel Belgium NV | Immediate release abuse deterrent formulations |
US11478426B2 (en) | 2018-09-25 | 2022-10-25 | SpecGx LLC | Abuse deterrent immediate release capsule dosage forms |
JP7552275B2 (ja) * | 2020-11-13 | 2024-09-18 | マツダ株式会社 | 自動変速機及び自動変速機の遠心バランス調整方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5745394A (en) | 1992-12-30 | 1994-08-15 | Fmc Corporation | Readily available konjac glucomannan sustained release excipient |
US5498436A (en) | 1993-12-30 | 1996-03-12 | Fmc Corporation | Coprocessed galactomannan-glucomannan |
US6733769B1 (en) | 1999-05-06 | 2004-05-11 | Opta Food Ingredients, Inc. | Methods for lowering viscosity of glucomannan compositions, uses and compositions |
US20030068375A1 (en) * | 2001-08-06 | 2003-04-10 | Curtis Wright | Pharmaceutical formulation containing gelling agent |
DE10250084A1 (de) * | 2002-10-25 | 2004-05-06 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
US20080152595A1 (en) * | 2004-11-24 | 2008-06-26 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of orally administered pharmaceutical products |
US20060110327A1 (en) * | 2004-11-24 | 2006-05-25 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of orally administered pharmaceutical products |
US20070128285A1 (en) | 2005-07-12 | 2007-06-07 | Chikara Jin | Pharmaceutical composition for oral administration |
AU2008207200B2 (en) * | 2007-01-16 | 2011-02-17 | Egalet Ltd | Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse |
BRPI0821732A2 (pt) * | 2007-12-17 | 2015-06-16 | Labopharm Inc | Formulações de liberação controlada , forma de dosagem sólida, e, uso da formulação de liberação controlada |
CA2733231A1 (en) | 2008-08-07 | 2010-02-11 | Avantor Performance Materials, Inc. | Sustained release compositions comprising gums and sugar alcohols |
-
2012
- 2012-09-28 CA CA2791206A patent/CA2791206A1/en not_active Abandoned
-
2013
- 2013-09-30 WO PCT/CA2013/000835 patent/WO2014047731A1/en active Application Filing
- 2013-09-30 EP EP13840242.5A patent/EP2900272B1/en active Active
- 2013-09-30 US US14/431,882 patent/US20150250886A1/en not_active Abandoned
- 2013-09-30 ES ES13840242.5T patent/ES2685965T3/es active Active
- 2013-09-30 CA CA2885676A patent/CA2885676C/en active Active
-
2015
- 2015-12-30 HK HK15112841.9A patent/HK1211859A1/xx unknown
-
2017
- 2017-12-27 US US15/855,704 patent/US20180117158A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2900272A4 (en) | 2016-04-13 |
WO2014047731A1 (en) | 2014-04-03 |
CA2791206A1 (en) | 2014-03-28 |
US20150250886A1 (en) | 2015-09-10 |
ES2685965T3 (es) | 2018-10-15 |
CA2885676A1 (en) | 2014-04-03 |
US20180117158A1 (en) | 2018-05-03 |
EP2900272A1 (en) | 2015-08-05 |
EP2900272B1 (en) | 2018-06-06 |
CA2885676C (en) | 2020-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1211859A1 (en) | Abuse deterrent pharmaceutical composition comprising konjac glucomannan | |
IL234996A0 (en) | Hand-release pharmacy preparations with properties to prevent abuse | |
IL234997B (en) | Immediate release pharmaceutical preparations designed to prevent abuse | |
IL236648A0 (en) | Delayed release abuse prevention pharmaceuticals | |
HK1210599A1 (en) | Abuse deterrent pharmaceutical compositions for controlled release | |
IL252566B (en) | Pharmacy preparations and methods | |
HK1209638A1 (en) | Pharmaceutical compositions | |
ZA201501930B (en) | Pharmaceutical composition | |
GB201318361D0 (en) | Content protection | |
AU344048S (en) | Barrier | |
EP2895982A4 (en) | HARDWARE-FORGET ACCESS PROTECTION | |
PL2817372T3 (pl) | Trwałe kompozycje polihydroksyalkanianowe | |
EP2832730A4 (en) | MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION | |
SG11201405575YA (en) | Modified polymer compositions | |
AU344047S (en) | Barrier | |
HK1210710A1 (en) | Pharmaceutical composition comprising rebamipide | |
AU344050S (en) | Barrier | |
AU344046S (en) | Barrier | |
EP2855590A4 (en) | POLYMER COMPOSITION | |
AU344045S (en) | Barrier | |
ZA201502987B (en) | Pharmaceutical composition | |
EP2885638A4 (en) | MOLECULAR NETS | |
GB201208315D0 (en) | Pharmaceutical methods and compositions | |
AU344049S (en) | Barrier | |
EP2897590A4 (en) | PHARMACEUTICAL COMPOSITION |